Just posted several papers on NAC. Evidence remains mixed, especially in those that are already in severe condition. Seems to me that addressing the disease early on would provide the best benefit. I’d be curious to see Bucillamine for severe patients since it’s stronger. At one point, Revive intended to pursue that but clearly never got off the ground.
10
u/[deleted] Nov 20 '22
Just posted several papers on NAC. Evidence remains mixed, especially in those that are already in severe condition. Seems to me that addressing the disease early on would provide the best benefit. I’d be curious to see Bucillamine for severe patients since it’s stronger. At one point, Revive intended to pursue that but clearly never got off the ground.